Stock Events

ProShares UltraShort Health Care -2x Shares 

$9.93
6
-$0.16-1.63% Today

Statistics

Day High
10.11
Day Low
9.8
52W High
14.02
52W Low
9.8
Volume
0
Avg. Volume
2,540
Mkt Cap
811,941
P/E Ratio
0
Dividend Yield
7.74%
Dividend
0.77

Upcoming

20
SEP
Dividend Ex
27
SEP
Dividend Payment
20
DEC
Dividend Ex
28
DEC
Dividend Payment
20
MAR 25
Dividend Ex
27
MAR 25
Dividend Payment
26
JUN 25
Dividend Ex
3
JUL 25
Dividend Payment
20
SEP 25
Dividend Ex
27
SEP 25
Dividend Payment

Dividends

7.74%Dividend Yield
Jul 24
$0.19
Mar 24
$0.13
Dec 23
$0.12
Sep 23
$0.09
Jun 23
$0.11
10Y Growth
N/A
5Y Growth
3.41%
3Y Growth
N/A
1Y Growth
85.79%

People Also Follow

This list is based on the watchlists of people on Stock Events who follow RXD. It's not an investment recommendation.
Alphabet
68918
GOOGL
Apple
60554
AAPL
Microsoft
56693
MSFT
Amazon
51850
AMZN

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
Direxion Daily Pharmaceutical & Medical Bull 3X Shares
PILL
Mkt Cap14.66M
Direxion Daily Pharmaceutical & Medical Bull 3X Shares, provides leveraged exposure opposite to RXD, making it a competitor for investors seeking inverse or leveraged plays in healthcare.
Direxion Daily Healthcare Bull 3X Shares
CURE
Mkt Cap198.76M
Direxion Daily Healthcare Bull 3X Shares, offers 3x daily long leverage to the healthcare sector, serving as a direct competitor for those looking at inverse healthcare investments like RXD.
ProShares UltraShort Nasdaq Biotechnology -2x Shares
BIS
Mkt Cap2.95M
ProShares UltraShort Nasdaq Biotechnology, offers 2x daily short leverage to the biotechnology sector, competing with RXD in the inverse healthcare and biotech investment space.
Direxion Daily S&P Biotech Bear 3X Shares
LABD
Mkt Cap131.45M
Direxion Daily S&P Biotech Bear 3X Shares, provides 3x daily short leverage to the biotechnology sector, a close competitor to RXD's healthcare focus.
Direxion Daily S&P Biotech Bull 3X Shares
LABU
Mkt Cap1.13B
Direxion Daily S&P Biotech Bull 3X Shares, offers 3x daily long leverage to the biotechnology sector, competing by providing an opposite market position to RXD.
iShares Biotechnology
IBB
Mkt Cap7.63B
iShares Nasdaq Biotechnology ETF, offers exposure to biotechnology and pharmaceuticals, competing with RXD by covering a significant part of the healthcare sector.
Health Care Select Sector SPDR
XLV
Mkt Cap40.47B
Health Care Select Sector SPDR Fund, provides broad exposure to the healthcare sector, competing with RXD by offering an alternative investment in healthcare.
Vanguard Health Care
VHT
Mkt Cap17.98B
Vanguard Health Care ETF, offers comprehensive coverage of the healthcare industry, serving as a competitor by providing an alternative to RXD's inverse strategy.
SPDR Biotech
XBI
Mkt Cap7.45B
SPDR S&P Biotech ETF, provides exposure to the biotechnology sector, competing with RXD by covering a similar segment of the healthcare market.

About

Miscellaneous
Investment Trusts/Mutual Funds
The fund invests in financial instruments that ProShare Advisors believes, in combination, should produce daily returns consistent with the fund's investment objective. The index is designed to measure the stock performance of U.S. companies in the healthcare industry. The fund is non-diversified.
Show more...
CEO
Country
US
ISIN
US74347G5642

Listings

ARCX
US
RXD